Reports for CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML

Brand name
CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML

Company Name

BRISTOL-MYERS SQUIBB CANADA

Drug Identification Number

02163675

Ingredients & Strength

Anatomical Therapeutical Chemical (ATC) Code

  • J01DC

Anatomical Therapeutical Chemical (ATC) Descriptor

  • OTHER BETA-LACTAM ANTIBACTERIALS

Status

CANCELLED POST MARKET
Shortage reports
Brand name Packaging size Status Date Created Date Updated Reports

Showing 1 to 0 of 0

Discontinuation reports
Brand name Packaging size Status Date Created Date Updated Reports
CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML 1 BTL X 75 mL and 1 BTL X 100 ML Discontinued 2017-06-05 2017-12-30 11847

Showing 1 to 1 of 1